THC2GO Dispensaries Submits Application to Manitoba Government For Retail Cannabis Stores.

THC2GO Dispensaries Submits Application to Manitoba Government For Retail Cannabis Stores.

THC Receives Health Canada Permission to Add 4 Extra Grow Rooms.

THC in Advanced Negotiations to Purchase Established Green House business in Ontario.

 

THC.CSE                                             THCBF – OTC                                              TFHC.F

VANCOUVER, December 20, 2017 – THC BioMed Intl Ltd. (“THC” or the “Company”) (CSE:THC) announces that its subsidiary, THC2GO Dispensaries Ltd, has officially submitted its application to operate cannabis retail stores in the province of Manitoba.

THC is also pleased to announce that Health Canada has amended THC’s ACMPR license to include 4 additional Grow Rooms. These additional Grow Rooms will allow THC to ramp up production, substantially adding an additional 400kg per annum. THC expects in the next few months to be the first Licensed Producer to offer a consistent supply of 21 different strains. The 4 Grow Rooms went into production on Friday the 15th December 2017.

THC further announces that it has entered into negotiations to purchase a greenhouse business in Ontario, Canada’s most populated province. The greenhouse business has been operating for more than 20 years and is well suited for growing cannabis. Successful completion of the acquisition would immediately give THC 100,000 square feet grow capacity with both facilities combined and an expansion capability of 300,000 square feet.

THC is further pleased to announce that it has had its facility inspected for Good Manufacturing Practices to enable the export of products to the European Union. We expect positive results from the inspection and hope to receive certification soon.

As legalization of cannabis sets in globally, we have seen a rapid demand for our cannabis products by the international market.

We are very satisfied with the progress we have made in 2017 and expect that our company outlook will demonstrate the rewards of our hard work. We take this opportunity to thank our shareholders for their patience and support. We wish you all a safe and festive Holiday Season

About THC

THC’s vision is to be on the leading edge of scientific research, development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.

 

Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com

 

President and CEO:

John Miller

THC Biomed Intl Ltd.
T: 1-844-THCMEDS
E: info@thcbiomed.com

 

Forward-Looking Information:

 

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC. Forward-looking information is based on certain key expectations and assumptions made by the management of THC. Although THC believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release and include that (a) the additional Grow Rooms will be completed and allow THC to ramp up production and add an additional 400kg per annum, (b) THC, the next few months, will be the first Licensed Producer to offer a consistent supply of 21 different strains, (c) THC will acquire a greenhouse business in Ontario and that it would give THC 100,000 square feet grow capacity with both facilities combined and an expansion capability of 300,000 square feet.(d) THC will receive positive results and certification from its facility inspected for Good Production Practices to enable the export of products to the European Union, (e) the company outlook will demonstrate the rewards of our hard work (f) THC’s vision is to be on the leading edge of scientific research, development of products and services related to the medical cannabis industry while creating a standard of excellence, (g) as the medical marijuana industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis and (h) THC will be in the forefront of this rapidly growing industry. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.